20/04/2014 10:15:43 Free Membership Login

   

Amgen Inc

Visual Financials
Company Name: Amgen Inc
Ticker Symbol: AMGN
WWW Address: http://www.Amgen.com
CEO: Robert Bradway
No. of Employees: 17,200
Common Issue Type: CS
Business Description:Amgen Inc. is a biotechnology medicines company. It discovers, develops, manufactures and delivers innovative human therapeutics.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 115.48 Down -0.06 114.08 117.3 115.61 117.19 115.02 3237632
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 87,188.2 755.0 0.00 6.75 1.88 17.0 0.0 128.96 - 94.15
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close115.46$
PE Ratio - LTM17.0
Market Capitalisation87,188.2mil
Latest Shares Outstanding755.0mil
Earnings pS (EPS)6.75$
Dividend pS (DPS)1.88¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee959,167$
Effective Tax Rate13.3%
Float678.4mil
Float as % of Shares Outstanding0.9%
Foreign Sales3,850mil
Domestic Sales13,415mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin82.1%
EBITDA Margin38.3%
Pre-Tax Profit Margin28.2%
Assets Turnover31.0%
Return on Assets (ROA)8.4%
Return on Equity (ROE)24.7%
Return on Capital Invested (ROCI)10.2%
Current Ratio3.4
Leverage Ratio (Assets/Equity)3.0
Interest Cover
Total Debt/Equity (Gearing Ratio)1.45
LT Debt/Total Capital57.0%
Working Capital pS25.72$
Cash pS0.00$
Book-Value pS29.27$
Tangible Book-Value pS-8.12$
Cash Flow pS8.22$
Free Cash Flow pS7.32$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.93
Price/Tangible Book Ratio0.00
Price/Cash Flow14.0
Price/Free Cash Flow15.7
P/E as % of Industry Group62.0%
P/E as % of Sector Segment12.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Dividend Declared Date03/05/2013
Dividend Ex-Date05/13/2013
Dividend Record Date05/15/2013
Dividend Pay Date06/06/2013
Dividend Amount470
Type of PaymentCash Payment
Dividend Rate1.88
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio8.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---3.214,770,74416,832,734
4 Weeks128.96111.39122.93-6.0-64,421,25588,425,113
13 Weeks128.96111.39119.03-2.9-43,745,754239,728,283
26 Weeks128.96109.71114.920.5-63,350,014418,751,762
52 Weeks128.9694.15111.383.7-163,378,907851,484,753
YTD128.96111.39--0.2-23,635,619269,035,830
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
114.25116.13121.97117.33114.810.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.040.30.07
Income0.040.30.03
Dividend0.6
Capital Spending0.01NA0.03
R&D1.62NA6.10
Normalized Inc.5.88NA5.34
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %4.74.710.8
Earnings %21.121.118.0
EPS %27.027.036.6
EPS $0.400.401.48
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio42.39
Current Ratio3.8
Quick Ratio (Acid Test)3.2
Liquidity Ratio (Cash)2.94
Receivables Turnover6.4
Average Collection Period56
Working Capital/Equity120.8
Working Capital pS30.44
Cash-Flow pS7.18
Free Cash-Flow pS2.23
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.80
Financial Leverage Ratio (Assets/Equity)2.8
Debt Ratio64.9
Total Debt/Equity (Gearing Ratio)1.39
LT Debt/Equity1.26
LT Debt/Capital Invested62.8
LT Debt/Total Liabilities68.2
Interest Cover5.8
Interest/Capital Invested2.28
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.60
Current P/E Ratio - LTM17.00
Enterprise Value (EV)/EBITDA14.08
Enterprise Value (EV)/Free Cash Flow47.50
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.93
Price/Cash Flow Ratio14.0
Price/Free Cash Flow Ratio - LTM15.7
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM18.1
P/E Ratio (26 weeks ago) - LTM16.0
P/E Ratio (52 weeks ago) - LTM16.5
5-Y High P/E Ratio19.4
5-Y Low P/E Ratio6.8
5-Y Average P/E Ratio14.1
Current P/E Ratio as % of 5-Y Average P/E32
P/E as % of Industry Group62.0
P/E as % of Sector Segment12.0
Current 12 Month Normalized P/E Ratio - LTM16.6
PER SHARE FIGURES
LT Debt pS31.78
Current Liabilities pS10.83
Tangible Book Value pS - LTM-8.12
Book Value pS - LTM29.27
Capital Invested pS57.08
Cash pS - LTM0.00
Cash Flow pS - LTM8.22
Free Cash Flow pS - LTM7.32
Earnings pS (EPS)6.75
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin9.76
Free Cash Flow Margin 5YEAR AVG28.11
Net Profit Margin25.2
Net Profit Margin - 5YEAR AVRG.0.3
Equity Productivity0.91
Return on Equity (ROE)22.8
Return on Equity (ROE) - 5YEAR AVRG.0.2
Capital Invested Productivity0.40
Return on Capital Invested (ROCI)10.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.30
Return on Assets (ROA)8.0
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin82.1
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM38.3
EBIT Margin - LTM31.4
Pre-Tax Profit Margin29.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.3
Effective Tax Rate13.3
Effective Tax Rate - 5YEAR AVRG.13.8
EFFICIENCY RATIOS
Cash Conversion Cycle495
Revenue per Employee959,167
Net Income per Employee241,389
Average Collection Period53
Receivables Turnover6.4
Day's Inventory Turnover Ratio443
Inventory Turnover0.8
Inventory/Sales15.9
Accounts Payble/Sales19.69
Assets/Revenue3.33
Net Working Capital Turnover0.75
Fixed Assets Turnover0.75
Total Assets Turnover0.3
Revenue per $ Cash5.30
Revenue per $ Plant3.24
Revenue per $ Common Equity0.91
Revenue per $ Capital Invested0.40
Selling, General & Adm/tive (SG&A) as % of Revenue27.8
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue19.6
R&D Expense as % of Revenue - 5YEAR AVRG.19.6

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq amgn140420 10:15